Life Sciences: Industry trends & investment considerations with Nick Galakatos, Blackstone
UBS On-Air: Market Moves
00:00
High Costs and Growing Demand for Drug R&D
Nick explains that developing a new medicine costs over $2 billion and innovation plus AI are increasing pipeline volume and costs.
Play episode from 00:48
Transcript
